• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成大麻素WIN 55,212-2可诱导人癌细胞系死亡。

The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines.

作者信息

Müller Leonie, Radtke Arlo, Decker Jennifer, Koch Michael, Belge Gazanfer

机构信息

Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany.

Department of Neuropharmacology - Brain Research Institute, University of Bremen, Bremen, Germany.

出版信息

Anticancer Res. 2017 Nov;37(11):6341-6345. doi: 10.21873/anticanres.12086.

DOI:10.21873/anticanres.12086
PMID:29061818
Abstract

BACKGROUND

Studies have revealed that cancer might be treated with cannabinoids since they can influence cancer cell survival. These findings suggest an alternative treatment option to chemo- and radiotherapy, that are associated with numerous adverse side-effects for the patients.

MATERIALS AND METHODS

Viability staining was conducted on lung cancer, testicular cancer and neuroblastoma cells treated with different concentrations of the synthetic cannabinoid WIN 55,212-2 and the percentage of dead cells was compared. Activity of apoptosis-related enzymes was investigated by the presence of DNA ladder in gel electrophoresis.

RESULTS

Treatment with different WIN 55,212-2 concentrations led to a significant dose-dependent reduction of cell viability. A DNA ladder was observed after WIN 55,212-2 treatment of testicular cancer and lung cancer cells.

CONCLUSION

The application of WIN 55,212-2 was found to trigger cell death in the investigated cell lines. The decline in lung cancer and testicular cancer cell viability seems to have been caused by apoptosis. These findings may contribute to development of alternative cancer therapy strategies.

摘要

背景

研究表明,大麻素可能对癌症具有治疗作用,因为它们能够影响癌细胞的存活。这些发现提示了一种替代化疗和放疗的治疗选择,化疗和放疗会给患者带来诸多不良副作用。

材料与方法

对用不同浓度的合成大麻素WIN 55,212-2处理的肺癌、睾丸癌和神经母细胞瘤细胞进行活力染色,并比较死细胞的百分比。通过凝胶电泳中DNA梯带的出现来研究凋亡相关酶的活性。

结果

用不同浓度的WIN 55,212-2处理导致细胞活力显著呈剂量依赖性降低。在用WIN 55,212-2处理睾丸癌细胞和肺癌细胞后观察到了DNA梯带。

结论

发现应用WIN 55,212-2可在研究的细胞系中引发细胞死亡。肺癌和睾丸癌细胞活力的下降似乎是由凋亡引起的。这些发现可能有助于开发替代性癌症治疗策略。

相似文献

1
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines.合成大麻素WIN 55,212-2可诱导人癌细胞系死亡。
Anticancer Res. 2017 Nov;37(11):6341-6345. doi: 10.21873/anticanres.12086.
2
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.合成大麻素WIN诱导HepG2细胞凋亡:转录因子PPARγ的作用
Biochimie. 2009 Apr;91(4):457-65. doi: 10.1016/j.biochi.2008.11.003. Epub 2008 Nov 27.
3
Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.大麻素 WIN 55,212-2 可诱导细胞周期停滞和细胞凋亡,并通过大麻素受体 2 依赖性方式抑制前列腺癌的增殖、迁移、侵袭和肿瘤生长。
Prostate. 2019 Feb;79(2):151-159. doi: 10.1002/pros.23720. Epub 2018 Sep 21.
4
The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.CB1/CB2受体激动剂WIN-55,212-2在体外可降低人卡波西肉瘤细胞的活力。
Eur J Pharmacol. 2009 Aug 15;616(1-3):16-21. doi: 10.1016/j.ejphar.2009.06.004. Epub 2009 Jun 17.
5
Involvement of the CB cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma.大麻素 CB 受体通过大麻素激动剂 WIN 55,212-2 参与肾细胞癌细胞生长抑制和 G0/G1 细胞周期阻滞。
BMC Cancer. 2018 May 23;18(1):583. doi: 10.1186/s12885-018-4496-1.
6
WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.WIN 通过依赖于 PPARγ 下调的自噬流阻滞诱导人结肠癌细胞发生凋亡性细胞死亡。
Apoptosis. 2014 Jun;19(6):1029-42. doi: 10.1007/s10495-014-0985-0.
7
Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells.大麻素受体激动剂作为氟尿嘧啶耐药胃癌细胞的替代药物。
Anticancer Res. 2013 Jun;33(6):2541-7.
8
The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.合成大麻素 WIN 55,212-2 通过激活 p8/CCAAT/增强子结合蛋白同源蛋白 (CHOP)/死亡受体 5 (DR5) 轴使肝癌细胞对肿瘤坏死因子相关凋亡诱导配体 (TRAIL) 诱导的细胞凋亡敏感。
Mol Pharmacol. 2010 May;77(5):854-63. doi: 10.1124/mol.109.062257. Epub 2010 Feb 16.
9
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.过氧化物酶体增殖物激活受体 γ 介导合成大麻素 WIN55,212-2 对人肝癌 BEL-7402 细胞增殖和凋亡的影响。
Mol Biol Rep. 2013 Nov;40(11):6287-93. doi: 10.1007/s11033-013-2741-x. Epub 2013 Sep 24.
10
The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor.合成大麻素WIN-55,212通过一种依赖CB1受体的机制诱导细胞滋养层细胞凋亡。
Toxicology. 2017 Jun 15;385:67-73. doi: 10.1016/j.tox.2017.04.013. Epub 2017 May 8.

引用本文的文献

1
Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy.四氢大麻酚:用于癌症治疗的潜在大麻模拟剂。
Cancer Metastasis Rev. 2023 Sep;42(3):823-845. doi: 10.1007/s10555-023-10078-2. Epub 2023 Jan 25.
2
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.大麻素类药物作为有前景的抗癌药物:在健康细胞和癌细胞中的作用机制。
Adv Exp Med Biol. 2023;1410:145-169. doi: 10.1007/5584_2022_748.
3
Synthetic Cannabinoid Agonist WIN 55212-2 Targets Proliferation, Angiogenesis, and Apoptosis MAPK/AKT Signaling in Human Endometriotic Cell Lines and a Murine Model of Endometriosis.
合成大麻素激动剂WIN 55212-2靶向人子宫内膜异位细胞系和子宫内膜异位症小鼠模型中的增殖、血管生成及细胞凋亡的MAPK/AKT信号通路。
Front Reprod Health. 2021 Oct 5;3:726936. doi: 10.3389/frph.2021.726936. eCollection 2021.
4
Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges.大麻素的抗菌和细胞毒性作用:具有未来展望和当前挑战的最新综述
Pharmaceuticals (Basel). 2022 Oct 6;15(10):1228. doi: 10.3390/ph15101228.
5
The Synthetic Cannabinoid WIN55,212-2 Can Disrupt the Golgi Apparatus Independent of Cannabinoid Receptor-1.合成大麻素 WIN55,212-2 可独立于大麻素受体 1 破坏高尔基体。
Mol Pharmacol. 2022 May;101(5):371-380. doi: 10.1124/molpharm.121.000377. Epub 2022 Mar 2.
6
Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.内源性大麻素系统与肿瘤微环境:抗癌方法的新交织联系。
Cells. 2021 Dec 2;10(12):3396. doi: 10.3390/cells10123396.
7
The Current and Potential Application of Medicinal Cannabis Products in Dentistry.药用大麻产品在牙科领域的当前及潜在应用
Dent J (Basel). 2021 Sep 10;9(9):106. doi: 10.3390/dj9090106.
8
Cannabinoids in the landscape of cancer.大麻素在癌症领域的应用。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2507-2534. doi: 10.1007/s00432-021-03710-7. Epub 2021 Jul 14.
9
Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.大麻素 WIN 55,212-2 通过触发 ROS 介导的信号通路抑制人神经胶质瘤细胞生长。
Biomed Res Int. 2021 Apr 22;2021:6612592. doi: 10.1155/2021/6612592. eCollection 2021.
10
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.大麻素和合成大麻素在临床实验模型中的新兴作用。
Adv Exp Med Biol. 2021;1264:47-65. doi: 10.1007/978-3-030-57369-0_4.